Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...

Artificial intelligence has already made its mark in commercial industries, and there's a good argument to be made that AI is most impactful in the drug discovery marketplace: Drug discovery companies ...

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

Pioneering AI technology successfully designs antibodies de novo for six therapeutic targets, including one without an ...

Why Google DeepMind, Perplexity, Khan Academy, Canva, and Salesforce are among Fast Company’s Most Innovative Companies for 2025.

Results for the Year Ended December 31, 2024 Revenue reached RMB1,986.7 million Gross profit amounted to RMB687.4 million Net profit recorded RMB222.0 ...

To wit: Y Combinator-backed Cambridge, U.K.-based ReactWise is using AI to speed up chemical manufacturing — a key step in bringing new drugs to market. Once a promising drug has been identified ...

"De novo antibody design has been one of the major challenges in AI-based drug discovery, requiring atomic-level precision to ensure specific binding to target epitopes," said Chaok Seok ...

Researchers studying Alzheimer’s disease are using artificial intelligence-powered databases to accelerate the drug discovery process by making it easier to sift through vast amounts of ...